05.12 2012 11:46:12go back
Veropharm reports weak results
by Anton Safonov
Veropharm has published operating and financial results for January-September, 2012, based on IFRS. The results are viewed as negative. Despite EBITDA margin expansion, revenue declined, as did net profit.
This research is available only to subscribers.
Please login to continue
To subscribe please contact us on firstname.lastname@example.org or +7 495 792-06-19